Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (SHE:002223)
China
· Delayed Price · Currency is CNY 29.34
+0.26 (0.89%)
Apr 29, 2026, 2:35 PM CST
SHE:002223 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Operating Revenue | 7,835 | 7,901 | 7,523 | 7,919 | 7,034 | 6,831 | Upgrade
|
| Other Revenue | 54.03 | 54.03 | 42.9 | 52.81 | 67.77 | 63.18 | Upgrade
|
| Revenue | 7,890 | 7,955 | 7,566 | 7,972 | 7,102 | 6,894 | Upgrade
|
| Revenue Growth (YoY) | 1.53% | 5.14% | -5.09% | 12.25% | 3.01% | 2.51% | Upgrade
|
| Cost of Revenue | 3,922 | 3,952 | 3,796 | 3,916 | 3,709 | 3,586 | Upgrade
|
| Gross Profit | 3,968 | 4,003 | 3,770 | 4,055 | 3,393 | 3,308 | Upgrade
|
| Selling, General & Admin | 2,287 | 2,239 | 1,790 | 1,499 | 1,452 | 1,334 | Upgrade
|
| Research & Development | 572.5 | 570.15 | 546.68 | 504.37 | 496.4 | 425.67 | Upgrade
|
| Other Operating Expenses | 142.06 | 28.89 | -1.69 | 32.96 | 44.67 | 31.99 | Upgrade
|
| Operating Expenses | 3,013 | 2,842 | 2,355 | 2,027 | 2,006 | 1,818 | Upgrade
|
| Operating Income | 955.14 | 1,161 | 1,415 | 2,029 | 1,387 | 1,490 | Upgrade
|
| Interest Expense | -5.43 | -6 | -20.73 | -58.55 | -57.74 | -30.49 | Upgrade
|
| Interest & Investment Income | 285.41 | 283.33 | 261.13 | 357.97 | 185.19 | 156.79 | Upgrade
|
| Currency Exchange Gain (Loss) | -43.53 | -43.53 | 19.69 | 3.66 | 99.33 | -0.04 | Upgrade
|
| Other Non Operating Income (Expenses) | -32.82 | -0.68 | -0.94 | -2.41 | -1.4 | -1.79 | Upgrade
|
| EBT Excluding Unusual Items | 1,159 | 1,394 | 1,674 | 2,329 | 1,612 | 1,614 | Upgrade
|
| Impairment of Goodwill | -7.76 | -7.76 | -22.39 | -40.95 | -77.43 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | -4.11 | 2.16 | 2.17 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.99 | 1.28 | 6.16 | 555.26 | 170.7 | 0.29 | Upgrade
|
| Asset Writedown | -1.1 | -1.33 | -2.09 | -13.66 | -1.99 | -0.86 | Upgrade
|
| Other Unusual Items | 297.9 | 297.9 | 277.31 | 23.03 | 136.63 | 85.75 | Upgrade
|
| Pretax Income | 1,449 | 1,684 | 1,933 | 2,849 | 1,842 | 1,702 | Upgrade
|
| Income Tax Expense | 158.63 | 200.36 | 128.56 | 472.36 | 269.73 | 217.82 | Upgrade
|
| Earnings From Continuing Operations | 1,290 | 1,484 | 1,804 | 2,376 | 1,573 | 1,484 | Upgrade
|
| Minority Interest in Earnings | -4.8 | -2.34 | 1.43 | 19.38 | 22.35 | -1.6 | Upgrade
|
| Net Income | 1,285 | 1,482 | 1,806 | 2,396 | 1,595 | 1,482 | Upgrade
|
| Net Income to Common | 1,285 | 1,482 | 1,806 | 2,396 | 1,595 | 1,482 | Upgrade
|
| Net Income Growth | -27.42% | -17.94% | -24.63% | 50.21% | 7.60% | -15.73% | Upgrade
|
| Shares Outstanding (Basic) | 1,002 | 1,001 | 998 | 994 | 991 | 995 | Upgrade
|
| Shares Outstanding (Diluted) | 1,002 | 1,001 | 998 | 994 | 991 | 995 | Upgrade
|
| Shares Change (YoY) | 0.41% | 0.36% | 0.35% | 0.35% | -0.42% | -1.02% | Upgrade
|
| EPS (Basic) | 1.28 | 1.48 | 1.81 | 2.41 | 1.61 | 1.49 | Upgrade
|
| EPS (Diluted) | 1.28 | 1.48 | 1.81 | 2.41 | 1.61 | 1.49 | Upgrade
|
| EPS Growth | -27.72% | -18.23% | -24.90% | 49.69% | 8.05% | -14.86% | Upgrade
|
| Free Cash Flow | 1,316 | 1,374 | 1,688 | 1,994 | 1,926 | 916.88 | Upgrade
|
| Free Cash Flow Per Share | 1.31 | 1.37 | 1.69 | 2.01 | 1.94 | 0.92 | Upgrade
|
| Dividend Per Share | 0.600 | 0.600 | 0.800 | 0.800 | 0.600 | 0.300 | Upgrade
|
| Dividend Growth | -25.00% | -25.00% | - | 33.33% | 100.00% | - | Upgrade
|
| Gross Margin | 50.29% | 50.32% | 49.83% | 50.87% | 47.77% | 47.99% | Upgrade
|
| Operating Margin | 12.11% | 14.60% | 18.70% | 25.45% | 19.53% | 21.61% | Upgrade
|
| Profit Margin | 16.29% | 18.63% | 23.87% | 30.05% | 22.46% | 21.50% | Upgrade
|
| Free Cash Flow Margin | 16.68% | 17.27% | 22.31% | 25.02% | 27.11% | 13.30% | Upgrade
|
| EBITDA | 1,199 | 1,399 | 1,628 | 2,236 | 1,586 | 1,677 | Upgrade
|
| EBITDA Margin | 15.20% | 17.59% | 21.51% | 28.04% | 22.33% | 24.33% | Upgrade
|
| D&A For EBITDA | 243.95 | 237.73 | 212.85 | 206.92 | 199.14 | 187.27 | Upgrade
|
| EBIT | 955.14 | 1,161 | 1,415 | 2,029 | 1,387 | 1,490 | Upgrade
|
| EBIT Margin | 12.11% | 14.60% | 18.70% | 25.45% | 19.53% | 21.61% | Upgrade
|
| Effective Tax Rate | 10.95% | 11.89% | 6.65% | 16.58% | 14.64% | 12.80% | Upgrade
|
| Revenue as Reported | 7,890 | 7,955 | 7,566 | 7,972 | 7,102 | 6,894 | Upgrade
|
| Advertising Expenses | - | 351.51 | 171.34 | 121.54 | 147.18 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.